Relapsing severe anaemia due to primary parvovirus B19 infection after renal transplantation: A case report and review of the literature

Nephrology Dialysis Transplantation

Volumn 22, Issue 12, 2007, Pages 3660-3663

  Beckhoff, Angelika ^a,c   Steffen, Ingrid ^a   Sandoz, Pierre ^b   Hirsch, Hans H ^a   Schaub, Stefan ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b Burgerspital Solothurn   (Switzerland)

^c Kantonsspital Luzern ^*  (Switzerland)

Author keywords

Anaemia; Parvovirus B19; Primary infection; Renal transplantation

Indexed keywords

BASILIXIMAB; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ALPORT SYNDROME; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; COMMUNICABLE DISEASE; ERYTHEMA INFECTIOSUM; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANEMIA; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; RECURRENCE; SEVERITY OF ILLNESS INDEX;

EID: 36749018125     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm531     Document Type: Article

References (15)

1. Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004; 350: 586-597
2. Eid AJ, Brown RA, Patel R, Razonable RR. Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis 2006; 43: 40-48
3. Moudgil A, Shidban H, Nast CC et al. Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulin. Transplantation 1997; 64: 1847-1850
4. Lui SL, Luk WK, Cheung CY, Chan TM, Lai KN, Peiris JS. Nosocomial outbreak of parvovirus B19 infection in a renal transplant unit. Transplantation 2001; 71: 59-64
5. Egbuna O, Zand MS, Arbini A, Menegus M, Taylor J. A cluster of parvovirus B19 infections in renal transplant recipients: a prospective case series and review of the literature. Am J Transplant 2006; 6: 225-231
6. Renoult E, Bachelet C, Krier-Coudert MJ, Diarrassouba A, Andre JL, Kessler M. Recurrent anemia in kidney transplant recipients with parvovirus B19 infection. Transplant Proc 2006; 38: 2321-2323
7. Kumar J, Shaver MJ, bul-Ezz S. Long-term remission of recurrent parvovirus-B associated anemia in a renal transplant recipient induced by treatment with immunoglobulin and positive seroconversion. Transpl Infect Dis 2005; 7: 30-33
8. Choi SH, Chang SP, Won JC et al. A case of persistent anemia in a renal transplant recipient: association with parvovirus B19 infection. Scand J Infect Dis 2002; 34: 71-75
9. Marchand S, Tchernia G, Hiesse C et al. Human parvovirus B19 infection in organ transplant recipients. Clin Transplant 1999; 13: 17-24
10. Wong TY, Chan PK, Leung CB, Szeto CC, Tam JS, Li PK. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus. Am J Kidney Dis 1999; 34: 1132-1136
11. Liefeldt L, Buhl M, Schweickert B et al. Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy. Nephrol Dial Transplant 2002; 17: 1840-1842
12. Schaffner A, Thomann B, Zala GF et al. Transient pure red cell aplasia caused by antilymphoblast globulin after cadaveric renal transplantation. Transplantation 1991; 51: 1018-1023
13. Kurtzman GJ, Cohen BJ, Field AM, Oseas R, Blaese RM, Young NS. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 1989; 84: 1114-1123
14. Isa A, Kasprowicz V, Norbeck O et al. Prolonged activation of virus-specific CD8pT cells after acute B19 infection. PLoS Med 2005; 2: e343. Epub 2005 Nov. 1
15. Tyndall A, Jelk W, Hirsch HH. Parvovirus B19 and erosive polyarthritis. Lancet 1994; 343: 480-481